missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. INSM2 Mouse anti-Human, Clone: INSM2/4291, Novus Biologicals™

INSM2 Mouse anti-Human, Clone: INSM2/4291, Novus Biologicals™

Mouse Monoclonal Antibody

£377.00

Specifications

Antigen INSM2
Clone INSM2/4291
Concentration 0.2 mg/mL
Dilution Immunohistochemistry-Paraffin 1 to 2 μg/mL, Protein Array
Applications ELISA, Peptide Array
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18698706
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP3-07402-100ug 		100 μg
£377.00
100µg
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

INSM2 Monoclonal specifically detects INSM2 in Human samples. It is validated for Immunohistochemistry-Paraffin, Protein Array.
Specifications

Specifications

INSM2
0.2 mg/mL
ELISA, Peptide Array
Unconjugated
Mouse
Human
insulinoma-associated 2, Nbla106, zinc finger protein IA-6
Recombinant fragment of human INSM2 protein (around aa 432-540) (exact sequence is proprietary)
Primary
Store at 4°C.
INSM2/4291
Immunohistochemistry-Paraffin 1 to 2 μg/mL, Protein Array
Monoclonal
Purified
RUO
10 mM PBS with 0.05% BSA
84684
IgG1 κ
Protein A or G purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.